Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

15 April 2014

Column Group nears $200m mark for second fund

biotech_lrg Biotech-focused investment firm The Column Group has passed the halfway mark for its $250m-targeting second venture capital fund, according to documents filed with US securities regulators.

8 April 2014

Lightstone Ventures secures more than $150m for debut fundp

life science test tube_sq Life sciences-focused venture capital firm Lightstone Ventures has passed the halfway mark for its debut fund, AltAssets has learned.

13 February 2014

Edgewater Capital Partners passes halfway point for $80m third fundp

Private equity firm Edgewater Capital Partners has passed the halfway mark for its latest fundraise, AltAssets has learned.

10 February 2014

Vatera Healthcare Partners leads $70m round for Melinta Therapeutics

pharmaceutical 12_sq Pharmaceutical company Melinta Therapeutics has raised $70m via its third round of funding, which was led by existing backer Vatera Healthcare Partners.

24 January 2014

Alibaba, Yunfeng back CITIC 21CN with $170m investment

china beijing_sq Chinese e-commerce company Alibaba Group and private equity firm Yunfeng have agreed to acquire a controlling interest in pharmaceutical information business CITIC 21CN.

22 January 2014

Warburg Pincus gets 3x return from JHP exit

pharmaceutical 12_sq Private equity firm Warburg Pincus is set to make a return of three times from the sale of specialty pharmaceutical company JHP Group.

22 January 2014

Venture capital-backed Dicerna prices IPO at $11 to $13 per share

dna Venture capital-backed RNA interference-based therapeutics developer Dicerna Pharmaceuticals has priced its IPO at $11 to $13 per share.

3 January 2014

Gene therapy company uniQure plans $75m Nasdaq IPO

stocks2_lrg Venture capital-backed gene therapy specialist uniQure plans to raise $75m via an IPO on the Nasdaq exchange, according to a filing with US securities regulators.

20 December 2013

Blackstone exits India’s Emcure Pharmaceuticals to Bain Capital

india5_lrg Blackstone has exited its investment in Indian company Emcure Pharmaceuticals to fellow private equity major Bain Capital.

16 December 2013

Three private equity firms make final bids for Ikaria

pharmaceutical 12_sq Specialty drug company Ikaria has reportedly received three final offers from private equity firms.

Page 1 of 41234

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014